Document:

EX-10.1

 Exhibit 10.1 

FORM OF 
 EXECUTIVE EMPLOYMENT
AGREEMENT 
 This Executive Employment Agreement (the “Agreement”) is made and entered on the date specified on the signature
page hereto, effective as of [                    ] (the “Effective Date”), by and between Express Scripts Holding Company, a Delaware
corporation (“ESHC”), and [                    ] (“Executive”). 

WHEREAS, the parties wish to enter into this Agreement to set forth the terms and conditions of Executive’s employment with the Company

 NOW, THEREFORE, in consideration of the premises and the mutual covenants herein and for other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows: 
 ARTICLE I 

DEFINITIONS 
 For purposes of this
Agreement, each term defined in the preamble and the recitals has the meaning assigned to it and each of the following terms shall have the following meanings: 

1.1 “Accrued Rights” has the meaning set forth in Section 4.1. 

1.2 “Annual Base Salary” means the base salary set forth in Section 3.1. 

1.3 “Annual Bonus” means Executive’s annual performance-based cash bonus paid out pursuant to the Annual Bonus Program, as
described in Section 3.2. 
 1.4 “Annual Bonus Program” means the annual performance-based cash bonus program established by
the Committee and the Board with respect to each fiscal year and pursuant to the applicable Incentive Plan. 
 1.5 “Board” means
the Board of Directors of ESHC. 
 1.6 “Cause” means: 

(a) any act or acts by Executive, whether or not in connection with Executive’s employment by the Company, constituting,
or Executive’s conviction or plea of guilty or nolo contendere (no contest) to (whether or not any right to appeal or vacate said conviction or plea has been or may be exercised), (i) a felony under applicable law or (ii) a misdemeanor
involving fraud, theft, dishonesty or moral turpitude; 
 (b) any act or acts of gross dishonesty, including, but not limited
to, directly or indirectly, the actual or attempted misappropriation by Executive of the Company’s or its clients’ funds or property, or the actual or attempted appropriation of a business opportunity of the Company, including knowingly
allowing or overlooking any such conduct; or any act or acts of gross misconduct in the performance of Executive’s duties hereunder; 

(c) any willful malfeasance or willful misconduct by Executive in connection with Executive’s duties hereunder or any act
or omission which is materially injurious to the financial condition or business reputation of the Company; or 
 (d) any
breach by Executive of the provisions of Sections 5.1 through 5.3 of this Agreement, or of the terms and provisions of the Nondisclosure and Noncompetition Agreement 

Notwithstanding the foregoing, the event(s) described in clause (c) of this Section 1.6 shall not be deemed to constitute
“Cause” if such event is (i) primarily the result of bad judgment or negligence on the part of Executive not rising to the level of gross negligence; or (ii) primarily because of an act or omission believed by Executive in good
faith to have been in, or not opposed to, the interests of the Company. 

 1.7 “Change in Control” means a Change in Control as that term is defined in the ESHC
2016 Long-Term Incentive Plan and any successors thereto, as amended from time to time. 
 1.8 “CIC Pro Rata Bonus” has the
meaning set forth in Section 4.2(b)(iv). 
 1.9 “CIC Severance Benefit” means a severance payment in an amount equal to: 

(a) twenty-four (24) months of Executive’s Annual Base Salary as in effect immediately prior to the Termination Date,
plus 
 (b) an amount equal to two hundred percent (200%) of the Target Bonus. 

1.10 “Code” means the Internal Revenue Code of 1986, as amended. 

1.11 “Committee” means the Compensation Committee of the Board. 

1.12 “Company” means ESHC and, where context requires, its affiliates. 

1.13 “Competitive Business” means a business that is, or will be, engaged wholly or primarily in the business of manufacturing,
purchasing, selling or supplying in the United States or Canada, or in any other country in which the Company conducts business, any product or service manufactured, purchased, sold, supplied, or provided by the Company (including, without
limitation, businesses which the Company has specific plans to conduct in the future and as to which Executive is aware of such planning) in the United States or Canada, or in any other country in which the Company conducts business, or which
provides or will provide consulting or advisory services, including but not limited to audit reviews and evaluations of requests for proposals, which concern or could affect any existing or prospective relationship between the Company and any third
party, including its customers, prospective customers, vendors, suppliers and drug manufacturers. 
 1.14 “Covered Equity Awards”
means the following awards granted to Executive under the Incentive Plan: any and all Options, Stock Appreciation Rights, Restricted Stock Units or Performance Shares (as such terms are defined in the applicable Incentive Plan) granted on or after
the Effective Date, but during the term of this Agreement. 
 1.15 “Covered Payments” means the amounts described in
Section 7.12. 
 1.16 “Deemed Retirement Date” means the later to occur of (a) the date six months after Executive
properly delivers a Notice of Retirement, or (b) the Termination Date. 
 1.17 “Disability” has the meaning ascribed to such
term in the ESHC 2016 Long-Term Incentive Plan and any successors thereto, as amended from time to time. 
 1.18 “Employment
Period” means the Initial Employment Period plus any additional Renewal Periods. 
 1.19 “Excise Tax” means the excise tax
imposed by Section 4999 of the Code or any similar state or local tax that may be imposed. 
 1.20 “Good Reason” means the
occurrence of any one or more of the following: 
 (a) Any material breach by the Company of any of the provisions of this
Agreement or any material failure by the Company to carry out any of its obligations hereunder; 
 (b) The Company’s
requiring Executive to be based at any office or location more than 50 miles from One Express Way, Saint Louis, Missouri (the “Current Headquarters”), except for travel reasonably required in the performance of Executive’s
responsibilities to the extent substantially consistent with Executive’s business travel obligations; 

 (c) Any substantial and sustained diminution in Executive’s authority or
responsibilities from those described in Section 2.3; provided, however, notwithstanding the foregoing, (i) in the event a Change in Control shall occur which results in ESHC becoming a subsidiary of another pharmacy benefit
management company (“PBM”), or which is in the form of a merger in which the surviving corporation or entity is a PBM (x) so long as Executive is offered a position and continues to be employed as an officer of the parent PBM (or
surviving corporation or entity) with duties and responsibilities which are not inconsistent in any material adverse respect with Executive’s duties and responsibilities immediately prior to such Change in Control, and such position is based at
an office or location not more than 50 miles from the Current Headquarters, such change in position shall not constitute Good Reason, but (y) if Executive is not offered a position as, or ceases to be employed as, an officer of the parent PBM
or surviving corporation or entity as described in (x), a substantial and sustained diminution in Executive’s authority or responsibility shall be deemed to have occurred; or (ii) in the event a Change in Control shall occur which results
in ESHC becoming a subsidiary of a non-PBM or is in the form of a merger in which the surviving corporation or entity is not a PBM, failure to receive an offer to serve as an officer of the non-PBM parent or surviving corporation or entity shall not constitute Good Reason provided Executive’s duties subsequent to the Change in Control are not inconsistent in any material adverse respect with
Executive’s duties immediately prior to the Change in Control, and such position is based at an office or location not more than 50 miles from the Current Headquarters; 

(d) The material diminution of the perquisites or benefits Executive enjoys in the aggregate under the Company’s benefit
programs (including long-term incentive compensation programs), such as any of the Company’s pension, savings, vacation, life insurance, medical, health and accident, disability or long-term incentive plans in which he or she was participating
at the time of any such material discontinuation (or, alternatively, if such plans are amended, modified or discontinued, material diminution of benefits thereunder in the aggregate), or the taking of any action by the Company which would directly
or indirectly cause such benefits to be materially diminished in the aggregate to the benefits in effect immediately prior to taking such action; provided, that a material diminution in the context of long-term incentives shall be measured based on
Executive’s long-term incentive opportunity; provided, further, that any amendment, modification or discontinuation of any plans or benefits referred to in this subsection (d) that generally affect substantially all other domestic salaried
employees of the Company who were eligible to participate, and participated, in the affected Company benefit program(s) shall not be deemed to constitute Good Reason; and 

(e) The failure of the Company to renew this Agreement for an additional Renewal Period under Section 2.2, unless the
current Employment Period is scheduled to end after Executive has attained the age of 65; 
 provided, that the events described in Section 1.20(a),
(b), (c) or (d) above shall only constitute Good Reason if the Company fails to cure such event within 30 days after receipt from Executive of written notice of the event which constitutes Good Reason; and provided, further that,
“Good Reason” shall cease to exist for an event on the 90th day following the later of its occurrence or Executive’s knowledge thereof, unless Executive has given the Company written notice thereof prior to such date. For the
avoidance of doubt, Executive’s voluntary resignation (other than in circumstances constituting Good Reason hereunder) or termination by the Company for Cause shall not constitute termination for Good Reason. 

1.21 “Incentive Plan” means the Express Scripts Holding Company 2016 Long-Term Incentive Plan, the Express Scripts, Inc. 2011
Long-Term Incentive Plan, the Express Scripts, Inc. 2000 Long-Term Incentive Plan, the Medco Health Solutions, Inc. 2002 Stock Incentive Plan, and in each case, any successors thereto, as amended from time to time. 

1.22 “Initial Employment Period” has the meaning set forth in Section 2.2. 

1.23 “Nondisclosure and Noncompetition Agreement” means any Form of Nondisclosure, Nonsolicitation, and Noncompetition Agreement
entered into or previously entered into by and between Executive and the Company, as may be amended from time to time, or any successor form agreement. 

 1.24 “Notice of Retirement” means a notice of any purported Retirement by Executive as
further described in Section 4.5(b). 
 1.25 “Notice of Termination” means a notice of any purported termination of
Executive’s employment by the Company or by Executive as further described in Section 4.5. 
 1.26 “Payment Cap” means
the maximum amount described in Section 7.12. 
 1.27 “Policy” has the meaning set forth in Section 7.16. 

1.28 “Post-Retirement Performance Share Factor” means a fraction determined as follows: 

(a) The numerator shall be the sum of (i) the number of calendar years in a Performance Period (as such term is defined in
the Incentive Plan) during which Executive was employed by the Company as of December 31 of such year, plus (ii) an additional one year for the calendar year in which the Termination Date occurs, provided that Executive was employed by the
Company during such year for at least three full calendar months prior to the Termination Date, and further provided that such additional year was not already included in this Section 1.28(a)(i) above (e.g., for a Performance Period of
January 1, 2015 through January 1, 2018, and a Termination Date of March 31, 2016 or thereafter, the numerator shall be two); and 

(b) The denominator shall be the number of full calendar years in a Performance Period (e.g., for a Performance Period of
January 1, 2015 through January 1, 2018, the denominator shall be three). 
 1.29 “Pro Rata Bonus” has the meaning set
forth in Section 4.2(a)(iv). 
 1.30 “Renewal Period” has the meaning set forth in Section 2.2. 

1.31 “Retirement” means (i) a Tenured Retirement or (ii) any termination of employment which becomes effective on or after
Executive has reached the age of 59 1⁄2, other than a termination of employment for Cause or due to death or Disability. 

1.32 “Senior Staff” means those members of the Company’s senior management team with a pay grade of M3 or higher, or a similar
level under any new or revised salary grading system utilized by the Company. 
 1.33 “Severance Benefit” means a severance
payment in an amount equal to: 
 (a) eighteen (18) months of Executive’s Annual Base Salary as in effect
immediately prior to the Termination Date, plus 
 (b) an amount equal to one hundred fifty percent (150%) of the Target
Bonus. 
 1.34 “Target Bonus” has the meaning set forth in Section 3.2. 

1.35 “Tenured Retirement” means a voluntary termination of employment by Executive which meets all of the following requirements:

 (a) Executive shall have properly delivered a Notice of Retirement at least six (6) months prior to the proposed
effective date of the Retirement; 
 (b) as of the date of proper delivery of the Notice of Retirement (i) Executive
shall be at least 55 years of age, (ii) Executive shall have served on Senior Staff for a continuous period of at least 3 years up to and including the date such Notice of Retirement is delivered, and (iii) the sum of Executive’s age
plus cumulative years of service with the Company equal at least 65. 
 1.36 “Termination Date” means the effective date of
termination of Executive’s employment as determined in accordance with Section 4.5. 

 1.37 “Termination Year” has the meaning set forth in Section 4.2(a)(iv). 

1.38 “Welfare Benefit” has the meaning set forth in Section 4.2. 

1.39 “Welfare Period” has the meaning set forth in Section 4.2. 

ARTICLE II 
 TERM/POSITION 

2.1 Employment; Effectiveness of Agreement. Effective as of the Effective Date, the Company employs Executive, and Executive accepts
such employment, according to the terms and conditions set forth in this Agreement. The parties acknowledge that Executive may be employed by ESHC or any of its subsidiaries or affiliated entities, and such employment shall be governed by this
Agreement. 
 2.2 Term. Unless terminated earlier pursuant to Sections 4.1 through 4.5 of this Agreement, the term of
Executive’s employment under this Agreement commenced on the Effective Date and continues through March 31, [        ] (the “Initial Employment Period”). On April 1 of each year,
commencing with April 1, [        ], and on each subsequent April 1 thereafter (each, an “Anniversary Date”), this Agreement shall be extended automatically at such time for an additional
twelve (12) month period or until such earlier termination pursuant to Sections 4.1 through 4.5 of this Agreement (each, a “Renewal Period”) unless either party hereto delivers written notice in accordance with Section 7.2 hereof
to the other party hereto at least 90 days prior to such Anniversary Date of his, her or its desire not to renew this Agreement for an additional Renewal Period (e.g. subject to the terms hereof, assuming an April 1 Anniversary Date, and an
employment period (Initial or Renewal) of April 1, 2017 through March 31, 2018, if either party gives proper notice at least 90 days prior to April 1, 2018 then the Agreement shall terminate as of March 31, 2018, but if neither
party gives proper notice at least 90 days prior to April 1, 2018 then the Agreement shall automatically renew for an additional Renewal Period of April 1, 2018 through March 31, 2019). The Initial Employment Period and any Renewal
Periods, if any, shall constitute the “Employment Period” for purposes of this Agreement. If there are no Renewal Periods, then the Employment Period shall have the same meaning as Initial Employment Period. Notwithstanding the foregoing,
upon a Change in Control, the Employment Period shall automatically extend for an additional number of months such that twenty-four (24) months remain in the Employment Period from the date of the Change in Control. Except as set forth in
Section 7.1, upon termination of Executive’s employment with the Company in accordance with the terms hereof or upon termination of the Initial Employment Period or the Employment Period without extension thereof, this Agreement shall
terminate and no longer be of any force or effect. 
 2.3 Position and Duties. Executive shall hold the position of [Senior]
[Executive] Vice President, [                    ] or such other title as the Company may ascribe to that position, or such other position of
relatively equivalent responsibility and authority to which the Company may assign Executive, and shall report to the Chief Executive Officer of the Company or such other executive officer of the Company as designated by the Chief Executive Officer
of the Company. During the Employment Period, Executive shall devote Executive’s best efforts and Executive’s full business time and attention (except for permitted vacation periods and reasonable periods of illness or other incapacity) to
the business affairs of the Company. Executive shall perform Executive’s duties and responsibilities to the best of Executive’s abilities in a diligent, trustworthy, businesslike and efficient manner. Nothing herein shall preclude
Executive from, (a) subject to the prior written consent of the Board, or an appropriate committee of the Board, serving on any for-profit corporate or governmental board of directors (b) serving on
the board of, or working for, any charitable, not-for-profit or community organization, (c) pursuing Executive’s personal, financial and legal affairs, or
(d) pursuing any other activity; provided, that Executive shall not engage in any other business, profession, occupation or other activity, for compensation or otherwise, which would violate the provisions of Section 5.1 or would,
in each case, and in the aggregate, otherwise conflict or interfere with the performance of Executive’s duties and responsibilities hereunder, either directly or indirectly, without the prior written consent of the Board or an appropriate
committee of the Board. 

 ARTICLE III 

COMPENSATION AND BENEFITS 
 3.1
Annual Base Salary. Effective as of the Effective Date and during the Employment Period following the Effective Date, the Company shall pay Executive a base salary (“Annual Base Salary”) at the annual rate of
[        ] Dollars ($[        ]), which shall be payable in regular installments in accordance with the Company’s usual payroll practices. Executive shall be
eligible for such increases in Executive’s Annual Base Salary, if any, as may be determined from time to time in the sole discretion of the Board or the Committee; provided, that any such increase shall not serve to limit or reduce any
other obligation to Executive under this Agreement. The term “Annual Base Salary” as used in this Agreement shall refer to the Annual Base Salary as in effect from time to time during the Employment Period. Executive’s Annual Base
Salary shall not be reduced after any such increase without Executive’s express written consent. 
 3.2 Annual Incentive
Compensation. Executive shall be eligible to participate in the Company’s Annual Bonus Program. The size of Executive’s bonus opportunity for any calendar year shall be no less than [    ] Percent
([    ]%) of Executive’s Annual Base Salary (the “Target Bonus”) for any calendar year, pro-rated for any modification during the year. Executive shall be eligible for
minimum Target Bonus opportunity increases, if any, as may be determined from time to time in the sole discretion of the Board or the Committee. Once increased, any such amount shall be the new minimum Target Bonus opportunity and “Target
Bonus” under the Agreement. The amount and terms of Executive’s participation in the Annual Bonus Program shall be determined based on the terms and conditions of the Annual Bonus Program (as approved at the sole discretion of the
Committee and the Board), subject to adjustment as described therein, and in accordance with any bonus award agreement thereunder. Executive’s Annual Bonus for the year of hire shall be based on Executive’s Annual Base Salary as in effect
on the Effective Date and pro-rated based on the number of days the Executive is employed with the Company during such calendar year. 

3.3 Participation in Benefit Plans. During the Employment Period, Executive shall be entitled to participate in the Company’s
employee benefit plans (other than bonus and incentive plans) as in effect from time to time, on the same basis as those benefits are generally made available to similarly situated senior executives of the Company. 

3.4 Restricted Stock, Stock Options and Other Equity Awards and Deferred Compensation. Executive may receive restricted stock, stock
options and other equity awards and deferred compensation, to the extent determined by the Company, the Board or the Committee, as applicable, from time to time. The terms of any such award shall be documented in a separate award notice or
agreement. 
 3.5 Business Expenses. During the Employment Period, Executive shall be reimbursed for all reasonable expenses incurred
by him or her in performing Executive’s duties hereunder provided that such expenses are incurred and accounted for in accordance with the policies and procedures established by the Company. 

3.6 Perquisites. During the Employment Period, Executive shall be entitled to receive such perquisites and fringe benefits which
similarly situated senior executives of the Company are entitled to receive and such other perquisites which are suitable to the character of Executive’s position with the Company and adequate for the performance of Executive’s duties
hereunder as determined by the Company from time to time. 
 ARTICLE IV 

TERMINATION OF EMPLOYMENT 
 4.1
Termination by the Company for Cause; Termination by Executive Other Than for Good Reason or Retirement. If the Employment Period and Executive’s employment under this Agreement are terminated by the Company for Cause or by Executive
other than for Good Reason or Retirement, prior to the scheduled expiration of the Employment Period, Executive shall be entitled to receive: 

(a) The Annual Base Salary through the Termination Date; 

(b) Reimbursement for any unreimbursed business expenses properly incurred by Executive in accordance with Company policy prior
to the Termination Date; and 

 (c) Such employee benefits, if any, to which Executive may be entitled under the
employee benefit plans of the Company, including rights with respect to any restricted stock, stock option and other equity awards or any deferred compensation, subject to the terms and conditions of the applicable plan, award, agreement or notice,
if relevant (the amounts described in clauses (a) through (c) being referred to as the “Accrued Rights”). The Accrued Rights shall not include any bonus payments in connection with any bonus plan, policy, practice, program or award.

 Following such termination of Executive’s employment hereunder pursuant to this Section 4.1, Executive shall have no further rights to any
compensation or any other benefits under this Agreement. Notwithstanding the delivery of a Notice of Termination or a Notice of Retirement (as applicable) with respect to a termination other than a termination by the Company under this
Section 4.1, the Company may, at any time on or prior to the Termination Date, exercise its right to terminate the Employment Period and Executive’s employment for Cause, and, upon the proper exercise of such right, any other purported
termination (including a purported Retirement) shall be null and void, and the terms of this Section 4.1 shall apply. In addition, notwithstanding the delivery of a Notice of Retirement by Executive, if the Employment Period and
Executive’s employment under this Agreement is terminated by Executive other than for Good Reason prior to the proposed effective date set forth in such Notice of Retirement, such purported Retirement (and the related Notice of Retirement)
shall be null and void, and the terms of this Section 4.1 shall apply. 
 4.2 Termination by the Company Other Than for Cause or
Disability; Termination by Executive for Good Reason. 
 (a) If the Employment Period and Executive’s employment
under this Agreement is terminated by the Company prior to the scheduled expiration of the Employment Period other than for Cause or Disability, or Executive terminates Executive’s employment prior to the scheduled expiration of the Employment
Period for Good Reason, in either case, prior to a Change in Control or following the two-year period following a Change in Control, Executive shall be entitled to receive: 

(i)    The Accrued Rights; 

(ii)    Any Annual Bonus earned for a previously completed fiscal year but unpaid as of the Termination
Date, which Annual Bonus shall be payable solely to the extent the applicable bonus payout is approved by the Committee; 

(iii)    A Severance Benefit pursuant to the terms and conditions set forth in Section 4.2(c) below; 

(iv)    An amount (to the extent such amount is approved for payout by the Committee and the Board in their
sole discretion) equal to the Annual Bonus that Executive would have been entitled to receive for the year in which the Termination Date occurs (the “Termination Year”) had Executive remained employed through the end of such year, which
amount, determined based on the Company’s actual performance for such year relative to the performance goals applicable to Executive, shall be prorated for the portion of the Termination Year in which Executive was employed by the Company (the
“Pro Rata Bonus”) and shall be payable in a lump sum at the same time bonuses are paid to other senior executives under the Annual Bonus Program, but in no event later than March 15th of the year following the Termination Year; and 

(v)    A payment from the Company in monthly installments, beginning on the first day of the first month
following the Termination Date (subject to the six-month delay described below), in an amount equal to the cost of continuing medical, dental, vision and EAP coverage under the Company’s medical, dental,
vision and EAP programs under COBRA for Executive’s applicable statutory COBRA period, for Executive and any eligible dependents of Executive (including Executive’s spouse) for a total period of eighteen (18) months (the “Welfare
Period”); provided that, (A) as of the Termination Date, Executive is covered under a Company plan for 

 
such medical, dental, vision and EAP coverage (as applicable), and the Company continues to offer such benefit to its
rank-and-file employees who are not covered under a collective bargaining agreement, (B) with respect to the medical benefits only, if during the Welfare Period,
the Company ceases to offer a medical program to its rank-and-file employees who are not covered under a collective bargaining agreement, the payment during the Welfare
Period shall change to an amount equal to the monthly premium for equivalent medical insurance coverage and (C) if during the Welfare Period Executive becomes eligible, as a full-time employee, for group medical, dental, vision and EAP
insurance from another employer, Executive shall forfeit (as applicable) any such future payments from the Company (collectively, the “Welfare Benefit”). Notwithstanding the foregoing, in the event such payments for continued coverage or
such continued coverage itself, by reason of change in the applicable law, may, in the Company’s reasonable view, result in tax or other penalties on the Company, this provision shall terminate and the parties shall, in good faith, negotiate
for a substitute provision which does not result in such tax or other penalties. 
 (b) If (1) a Change in Control
occurs during the Employment Period, and (2) if the Employment Period and Executive’s employment under this Agreement is terminated by the Company prior to the scheduled expiration of the Employment Period other than for Cause or
Disability, or Executive terminates Executive’s employment prior to the scheduled expiration of the Employment Period for Good Reason, in either case, within two (2) years after such Change in Control, Executive shall be entitled to
receive: 
 (i) The Accrued Rights; 

(ii) Any Annual Bonus earned for a previously completed fiscal year but unpaid as of the Termination Date, which Annual Bonus
shall be payable solely to the extent the applicable bonus payout is approved by the Committee; 
 (iii) A CIC Severance
Benefit pursuant to the terms and conditions set forth in Section 4.2(c) below; 
 (iv) An amount equal to the Target Bonus,
prorated for the portion of the Termination Year in which Executive was employed by the Company (the “CIC Pro Rata Bonus”) which shall be payable in a lump sum within sixty (60) days following the Termination Date; and 

(v) The Welfare Benefit. 

(c) The Company shall pay the Severance Benefit, without interest thereon (except as described in Section 7.18), in
eighteen (18) substantially equal monthly installments, which installments shall be payable on the first day of each month, with the first installment payable in the first full month commencing fifteen (15) days after the Termination Date
(subject to Section 4.2(d) and the six-month delay described in Section 7.18). The Company shall pay the CIC Severance Benefit, without interest thereon (except as described in Section 7.18), in
twenty-four (24) substantially equal monthly installments, which installments shall be payable on the first day of each month, with the first installment payable in the first full month commencing fifteen (15) days after the Termination
Date (subject to Section 4.2(d) and the six-month delay described in Section 7.18). Executive shall not be under any duty to mitigate damages in order to be eligible to receive the Severance Benefit or
the CIC Severance Benefit. 
 (d) Notwithstanding the foregoing, Executive agrees that the Company’s obligation to pay
the Severance Benefit, the CIC Severance Benefit, the Welfare Benefit, the bonuses pursuant to Sections 4.2(a)(ii), 4.2(a)(iv), 4.2(b)(ii) and 4.2(b)(iv), if applicable, is contingent and conditioned upon both of the following: 

(i) Executive’s full compliance with Sections 5.1 through 5.3 and Section 5.7, as well as any agreements in the
release described in Section 4.2(d)(ii) below, or of the terms and provisions of the Nondisclosure and Noncompetition Agreement or any other nondisclosure or noncompetition agreement between Executive and the Company that remains in effect.

 
Notwithstanding anything herein, if either (A) Executive breaches any of the provisions of Sections 5.1 through 5.3 or Section 5.7 (or any breach of any agreements in the release
described in Section 4.2(d)(ii) below, or in the Nondisclosure and Noncompetition Agreement, or in any other nondisclosure or noncompetition agreement between Executive and the Company that was in effect as of the time of such breach), or
(B) following the Termination Date the Committee becomes aware of acts or omissions by Executive during the term of Executive’s employment with the Company which would have constituted Cause, or (C) Executive, or anyone on
Executive’s behalf, pursues any type of action or claim against the Company regarding this Agreement or any topic or claim covered by this Agreement, other than (i) in connection with any challenges to the validity of the release described
in Section 4.2(d)(ii) below under the federal Age Discrimination in Employment Act as amended by the Older Worker Benefit Protection Act, (ii) in connection with the filing of a charge or complaint with or the participation in an investigation,
hearing or proceeding of a government agency or (iii) as otherwise prohibited by law, then, in each case, Executive shall reimburse the Company for all compensation or other amounts previously paid, allocated, accrued, delivered or provided by
the Company to Executive pursuant to Section 4.2(a) or 4.2(b) and the Company shall be entitled to discontinue the future payment, delivery, allocation, accrual or provision of the Severance Benefit, the CIC Severance Benefit, the Pro Rata Bonus,
the CIC Pro Rata Bonus, the Welfare Benefit and such other compensation, including any deferred or equity compensation, as reflected in the terms of any plan, notice or agreement evidencing such other compensation, except to the extent prohibited by
applicable law. 
 (ii) No later than sixty (60) days after the Termination Date, Executive must execute and deliver
(and not revoke) a general release releasing all claims against the Company (other than those specifically described in the below proviso) in such form and containing such terms as the Company may reasonably prescribe (and all applicable revocation
periods must have expired); provided, however, that in no event shall the timing of Executive’s execution (and non-revocation) of the general release, directly or indirectly, result in
Executive designating the calendar year of payment, and if a payment that is subject to execution (and non-revocation) of the general release could be made in more than one taxable year, payment shall be made
in the later taxable year; provided, further, that it shall not be a condition to Executive’s receipt of such payments that Executive release the Company from any of the following: 

(A) the obligations of the Company described in Article IV of this Agreement; or 

(B) any vested rights that Executive may have with respect to any benefits, rights or entitlements under the terms of any
employee benefit programs of the Company to which Executive is or will be entitled by virtue of Executive’s employment with the Company or any of its subsidiaries, and nothing in the release will prohibit or be deemed to restrict Executive from
enforcing Executive’s rights to any such benefits, rights or entitlements; or 
 (C) Executive’s right to
indemnification to the extent provided in the Company’s Certificate of Incorporation and/or bylaws. 
 Failure or refusal by Executive to execute and
deliver timely (and not revoke) such release shall release the Company from its obligations to make the payments described herein. Following such termination of Executive’s employment hereunder pursuant to this Section 4.2, Executive shall
have no further rights to any compensation or any other benefits under this Agreement. 
 4.3 Termination Due to Death, Disability or
Retirement. 
 (a) Rights Upon Termination. If the Employment Period and Executive’s employment under this
Agreement are terminated due to Executive’s death, Disability or Retirement prior to the scheduled expiration of the Employment Period, Executive or Executive’s estate, as applicable, will receive (a) the Accrued Rights plus any
Annual Bonus earned for a previously completed fiscal year but unpaid as of the 

 
Termination Date which Annual Bonus shall be payable solely to the extent the applicable bonus payout is approved by the Committee; provided, however, that, in the event of
Executive’s death, the Company agrees to abide by previously received written instructions from Executive directing the Company to pay the Accrued Rights and/or the accrued but unpaid Annual Bonus to a living trust or similar estate planning
vehicle of Executive, provided such trust or similar vehicle is still in existence at the time of Executive’s death, except to the extent prohibited by law, and except as may otherwise be required or directed by any applicable employee benefit
plan; and (b) payment for the Welfare Benefit; provided, however, in the event such continued coverage, by reason of change in the applicable law, may, in the Company’s reasonable view, result in tax or other penalties on the
Company, this provision shall terminate and the parties shall, in good faith, negotiate for a substitute provision which does not result in such tax or other penalties. Following such termination of Executive’s employment hereunder pursuant to
this Section 4.3, Executive shall have no further rights to any compensation or any other benefits under this Agreement. Further, notwithstanding the specific terms of the Incentive Plan or any award agreement thereunder, with respect to
Covered Equity Awards, a Retirement under this Agreement which is not also a Tenured Retirement shall be deemed to be a “Retirement” under the Incentive Plan and shall be treated in accordance with the provisions of the Incentive Plan and
any applicable award agreements which apply upon a “Retirement”. 
 (b) Tenured Retirement. Notwithstanding
the specific terms of the Incentive Plan or any award agreements thereunder, with respect to any Covered Equity Awards, upon a Tenured Retirement, the following provisions shall apply: 

(i) Vested Options and Stock Appreciation Rights. All Options or Stock Appreciation Rights which have vested on or prior
to the Termination Date, but which have not expired, been exercised, or otherwise terminated, shall remain vested and exercisable through the expiration of their respective terms (as set forth in the applicable option or stock appreciation rights
agreements or notices) and shall thereafter terminate. 
 (ii) Unvested Options and Stock Appreciation Rights. All
Options or Stock Appreciation Rights which have not vested as of the Termination Date, and which have not expired or otherwise terminated, shall continue to vest after the Termination Date in accordance with their respective terms as if Executive
were still employed by the Company, and shall remain vested and exercisable through the expiration of their respective terms (in each case as set forth in the applicable option or stock appreciation rights agreements or notices) and shall thereafter
terminate. 
 (iii) Restricted Stock Units. All grants of Restricted Stock Units which have not vested as of the
Termination Date, and which have not expired or otherwise terminated, shall continue to vest after the Termination Date in accordance with their respective terms as if Executive were still employed by the Company (as set forth in the applicable
restricted stock unit agreements or notices) and shall be paid in accordance with the vesting schedule as set forth in the applicable restricted stock unit agreement. 

(iv) Performance Shares. For each award of Performance Shares, to the extent not already vested, terminated or forfeited
as of the Termination Date, Executive shall be considered vested in such Performance Shares, but only to the extent the Performance Criteria (as defined in the applicable Performance Share award agreement) are achieved at the end of the applicable
performance period (subject to the limitations set forth below in this Section 4.3(b)(iv)), and any payment of shares shall be made in accordance with the terms of the applicable Performance Share agreement as if Executive had remained as an
employee of the Company through the end of the performance period (i.e. generally shares would not be distributed until after the end of the performance period). Notwithstanding the foregoing, certain Performance Shares shall be subject to a
reduction in the maximum number of shares which may be delivered, as follows: 
 (A) For each award of Performance Shares,
if Executive’s Termination Date occurs on or after the end of the third calendar month of the final full year of the applicable Performance Period (as such term is defined in the Incentive Plan) (e.g., for a Performance Period of
January 1, 2015 through January 1, 2018, on or after March 31, 2017), then such Performance Shares shall be treated as described in the preceding paragraph without any reduction in the maximum number of shares which may be delivered.

 (B) For each award of Performance Shares, if Executive’s Termination Date
occurs prior to the end of the third calendar month of the final full year of the applicable Performance Period (e.g., for a Performance Period of January 1, 2015 through January 1, 2018, before March 31, 2017), then such Performance
Shares shall be multiplied by the Post-Retirement Performance Share Factor, and the product shall be treated as described in the initial paragraph of this Section 4.3(b)(iv) without any reduction in the maximum number of shares which may be
delivered with respect to such portion of the Performance Shares. The remaining portion of the Performance Shares shall be treated as described in the initial paragraph of this Section 4.3(b)(iv) with a maximum payout of 100% (or
“target” number) of such remaining portion of the Performance Shares. 
 EXAMPLE: For an award of 150 Performance Shares, with a
Post-Retirement Performance Share Factor of two-thirds, assuming the achievement of the applicable Performance Criteria results in a payment of 200% of the target number of Performance Shares, Executive would
receive 250 shares determined as follows: 150 Performance Shares multiplied by the Post-Retirement Performance Share Factor results in 100 Performance Shares which are not subject to the 100% maximum and are thus paid out as 200 shares (100
Performance Shares * 200% payout factor); the remaining 50 Performance Shares are capped at a 100% payout factor and are thus paid out as 50 shares. 

(c) Notwithstanding anything to the contrary set forth herein, if either (i) Executive breaches any of the provisions of
Sections 5.1 through 5.3 or Section 5.7, or of the terms and provisions of the Nondisclosure and Noncompetition Agreement (whether such breach occurs during or after Executive’s employment with the Company), or (ii) following the
Termination Date the Committee becomes aware of acts or omissions by Executive during the term of Executive’s employment with the Company which would have constituted Cause, or (iii) Executive, or anyone on Executive’s behalf, pursues
any type of action or claim against the Company, regarding this Agreement or any topic or claim covered by this Agreement, other than (i) in connection with any challenges to the validity of the release described in Section 4.2(d)(ii) under the
federal Age Discrimination in Employment Act as amended by the Older Worker Benefit Protection Act, (ii) in connection with the filing of a charge or complaint with or the participation in an investigation, hearing or proceeding of a government
agency or (iii) as otherwise prohibited by law, then, in each case, (1) all Options, Stock Appreciation Rights, Restricted Stock Units, Performance Shares or other Awards (as defined in the Incentive Plan), to the extent not previously
exercised or paid out, shall immediately terminate and be forfeited, and Executive shall reimburse the Company for the value of any other Options, Stock Appreciation Rights, Restricted Stock Units, Performance Shares or other Awards for which
vesting accelerated, or which Executive otherwise realized value, as a result of a purported Retirement; and (2) Executive shall reimburse the Company for all compensation or other amounts previously paid, allocated, accrued, delivered or
provided by the Company to Executive pursuant to this Section 4.3 and the Company shall be entitled to discontinue the future payment, delivery, allocation, accrual or provision of the Severance Benefit, the CIC Severance Benefit, the Pro-Rata Bonus, the CIC Pro Rata Bonus, the Welfare Benefit and such other compensation, including any deferred or equity compensation, as reflected in the terms of any plan, notice or agreement evidencing such
other compensation, except to the extent prohibited by applicable law. 
 (d) If the Employment Period and Executive’s
employment under this Agreement are terminated due to Executive’s death, Disability or Retirement prior to the scheduled expiration of the Employment Period, Executive or Executive’s estate, as applicable, will receive a Pro Rata Bonus and
shall be payable, solely to the extent the applicable bonus payout is approved by the Committee, in a lump sum at the same time bonuses are paid to other senior executives under the Annual Bonus Program, but in no event later than March 15th of the
year following the Termination Year. 

 (e) In the event the Employment Period and Executive’s employment under this
Agreement are terminated due to Executive’s death or Disability prior to the scheduled expiration of the Employment Period, and, as of the Termination Date, Executive would have been eligible for Tenured Retirement, then, to the extent
permitted under Section 409A of the Code, Executive’s termination of employment shall be treated as a Tenured Retirement with respect to the Covered Equity Awards with a Deemed Retirement Date that is six (6) months following the
Termination Date. Notwithstanding the foregoing, Executive or Executive’s estate, as applicable, to the extent permitted under Section 409A of the Code, may decline such Tenured Retirement through an election delivered by written notice to the
Company not less than ninety (90) days following the Termination Date. If proper election is made under this paragraph, then Section 4.3(b) shall not apply to the Covered Equity Awards and the provisions of the Incentive Plan, and/or the
agreements or notices for the Covered Equity Awards, related to vesting, termination or forfeiture, or exercise period, following a termination due to death or Disability, shall apply to the Covered Equity Awards (except to the extent provided
herein). 
 (f) Any payment or vesting of cash or equity to Executive is subject to all federal, state, and local income and
payroll tax withholding that, in the opinion of the Company, is required by law. Unless Executive satisfies any such tax withholding obligation by paying the amount in cash (including by check or wire transfer) or shares of the Company’s stock,
the Company shall withhold cash and/or shares on the date of withholding sufficient to cover the withholding obligation or such other amount that will not cause adverse accounting consequences for the Company and is permitted under applicable
withholding rules promulgated by the Internal Revenue Service or another governmental entity, with shares valued in the same manner as used in computing the withholding taxes. 

(g) Notwithstanding the foregoing, Executive agrees that the Company’s obligation to make the payments set forth in this
Section 4.3, other than the Accrued Rights, is contingent and conditioned upon the execution and delivery (and non-revocation) of a general release by Executive (or Executive’s estate, if
applicable), no later than sixty (60) days after the Termination Date, releasing all claims against the Company (other than those specifically described in the below provisos) in such form and containing such terms as the Company may reasonably
prescribe; provided, however, that in no event shall the timing of Executive’s execution (and non-revocation) of the general release, directly or indirectly, result in Executive designating
the calendar year of payment, and if a payment that is subject to execution (and non-revocation) of the general release could be made in more than one taxable year, payment shall be made in the later taxable
year; provided, further, that it shall not be a condition to Executive’s receipt of such payments that Executive release the Company from any of the following: 

(i) the obligations of the Company described in Article IV of the Agreement; or 

(ii) any vested rights that Executive may have with respect to any benefits, rights or entitlements under the terms of any
employee benefit programs of the Company to which Executive is or will be entitled by virtue of Executive’s employment with the Company or any of its subsidiaries, and nothing in the release will prohibit or be deemed to restrict Executive from
enforcing Executive’s rights to any such benefits, rights or entitlements; or 
 (iii) Executive’s right to
indemnification to the extent provided in the Company’s Certificate of Incorporation and/or bylaws. 
 Failure or refusal by Executive
to execute and deliver timely (and not revoke) such release shall release the Company from its obligations to make the payments described herein. Following such termination of Executive’s employment hereunder pursuant to this Section 4.3,
Executive shall have no further rights to any compensation or any other benefits under this Agreement. 
 4.4 Expiration of the
Employment Period. 
 (a) In the event either party elects not to extend the Employment Period pursuant to
Section 2.2, unless Executive’s employment is earlier terminated pursuant to Sections 4.1 through 4.3, the Agreement shall terminate upon the expiration of the then current Employment Period subject only to

 
Section 7.1 and Executive’s employment with the Company beyond the expiration of the Employment Period shall be deemed an employment at-will and
shall not be deemed to extend any of the provisions of this Agreement (subject to Section 7.1) and Executive’s employment may thereafter be terminated at will by either Executive or the Company. 

(b) Following such termination of the Agreement pursuant to this Section 4.4, Executive shall have no further rights to
any compensation or any other benefits under this Agreement. 
 4.5 Notice of Termination; Notice of Retirement; Termination Date.

 (a) For purposes of this Agreement, any purported termination of Executive’s employment by the Company or by
Executive (other than a Retirement by Executive), shall be communicated by written “Notice of Termination” to the other party hereto in accordance with Section 7.2. Any Notice of Termination shall set forth (i) the effective date
of termination (for purposes of determining Executive’s entitlement to benefits hereunder), which, in the case of a termination by Executive pursuant to Section 4.1, or a termination by either party pursuant to Section 4.2 shall not
be less than fifteen (15) days after the date the Notice of Termination is delivered; (ii) the specific provision in this Agreement relied upon; and (iii) except in the case of a termination due to death, Disability or by the Company
other than for Cause, death or Disability, in reasonable detail, the facts and circumstances claimed to provide a basis for such termination. 

(b) For purposes of this Agreement, any purported Retirement by Executive shall be communicated by written “Notice of
Retirement” to the Company in accordance with Section 7.2. Any Notice of Retirement shall include the following (i) if Executive intends for the Retirement to qualify as a Tenured Retirement, the notice shall indicate such intent; and
(ii) the notice shall set forth the proposed effective date of the Retirement, which, for a Tenured Retirement shall not be less than six (6) months after the date the Notice of Retirement is delivered, or for any other Retirement shall
not be less than fifteen (15) days after the date the Notice of Retirement is delivered. Notwithstanding anything to the contrary set forth herein, in order for a Notice of Retirement to be proper and valid, Executive must, during the period
from delivery of the purported Notice of Retirement through the Termination Date, continue to substantially perform Executive’s duties hereunder, to the extent required by the Company. Executive’s material neglect or willful and continuous
failure to perform such duties, which neglect or failure is not cured within seven (7) days following written notice thereof from the Company to Executive, shall (i) invalidate the Notice of Retirement ab initio, and (ii) deprive
Executive the right to deliver a subsequent Notice of Retirement. However, the foregoing shall not prevent the Company, in its sole discretion, from agreeing to reduce or diminish Executive’s duties and obligations to the Company during the
period following delivery of the purported Notice of Retirement through the Termination Date. 
 (c) If the Company
terminates Executive’s employment pursuant to Section 4.1 or due to Executive’s Disability pursuant to Section 4.3, the Termination Date shall be the date upon which the Company notifies Executive of such termination. If the
Company terminates Executive’s employment pursuant to Section 4.2 or 4.3, or if Executive terminates employment pursuant to Section 4.1, 4.2 or 4.3, the Termination Date shall be Executive’s last full day of work prior to the
effectiveness of such termination. At any time following proper delivery of a Notice of Retirement but prior to the effective date of such Retirement, the Company may elect to terminate the Employment Period and Executive’s employment under
this Agreement in which case the Termination Date shall be Executive’s last full day of work prior to the effectiveness of such termination; provided, however, that, unless such termination is for Cause under Section 4.1,
such early termination by the Company shall not have any impact on the Deemed Retirement Date. Notwithstanding the foregoing, if within fifteen (15) days after any Notice of Termination is given, the party receiving such Notice of Termination
notifies the other party that a good faith dispute exists concerning the termination, the “Termination Date” for purposes of determining Executive’s entitlement to benefits under this Agreement shall be the date on which the dispute
is finally determined by an independent arbitrator selected by the American Arbitration Association. 
 4.6 Board/Committee
Resignation. Upon termination of Executive’s employment for any reason, Executive hereby agrees to immediately resign from all positions (including, without limitation, any management, officer or director position) that Executive holds on
the date of such termination with the Company or any of its 

 
affiliates or with any entity in which the Company or any of its affiliates has made any investment. Executive hereby agrees to execute and deliver such documentation reasonably required by the
Company as may be necessary or appropriate to enable the Company or its affiliates, or any entity in which the Company or any of its affiliates thereof has made an investment to effectuate such resignation, and in any case, Executive’s
execution of this Agreement shall be deemed the grant by Executive to the officers of the Company of a limited power of attorney to sign in Executive’s name and on Executive’s behalf such documentation solely for the limited purposes of
effectuating such resignation. 
 ARTICLE V 

RESTRICTIVE COVENANTS 
 For the purposes of this
Article V, all references to the Company shall include the Company and its affiliates. 
 5.1
Non-Solicitation and Non-Competition. 

(a) Executive acknowledges and recognizes the highly competitive nature of the businesses of the Company and accordingly agrees
as follows: 
 (i) During the period of Executive’s employment with the Company and, for a period of two
(2) years after termination of Executive’s employment for any reason by Executive or the Company (cumulatively the “Nonsolicit Period”), Executive will not, whether on Executive’s own behalf or on behalf of or in
conjunction with any person, firm, partnership, joint venture, association, corporation or other business organization, entity or enterprise whatsoever (“Person”), directly or indirectly solicit or assist in soliciting to provide products
or services manufactured, sold, supplied or provided by the Company to any actual or prospective client, vendor, supplier, drug manufacturer, broker, regional marketing director, employee benefit plan or trust, or other party in any type of business
relationship with the Company or encourage any such Person to reduce, terminate or change the terms of business conducted with the Company, in each case: 

(A) with whom Executive had personal contact or dealings on behalf of the Company during the one (1) year period
preceding Executive’s termination of employment; 
 (B) with whom employees reporting directly to Executive or to
Executive’s direct reports have had personal contact or dealings on behalf of the Company during the one (1) year immediately preceding Executive’s termination of employment; or 

(C) for whom Executive had direct or indirect responsibility during the one (1) year immediately preceding
Executive’s termination of employment. 
 (ii) During the Nonsolicit Period, Executive will not, whether on
Executive’s own behalf or on behalf of or in conjunction with any Person, directly or indirectly: 
 (A) solicit or
encourage any employee of the Company to leave the employment of the Company; or 
 (B) hire any such employee who was
employed by the Company as of the date of Executive’s termination of employment with the Company or who left the employment of the Company coincident with, or within one year prior to or after, the termination of Executive’s employment
with the Company. 
 (iii) During the Nonsolicit Period, Executive will not, directly or indirectly, solicit, or encourage to
cease to work with the Company, any consultant or independent contractor then under contract with the Company. 

 (iv) During the period of Executive’s employment with the Company and, for a
period of (18) months after termination of Executive’s employment for any reason by Executive or the Company (cumulatively the “Noncompete Period”), Executive will not directly or indirectly: 

(A) engage in or prepare to engage in any Competitive Business; 

(B) enter the employ of, or render any services to, any Person (or any division or controlled or controlling affiliate of any
Person) who or which engages in or is preparing to engage in a Competitive Business; 
 (C) acquire a financial interest in,
or otherwise become actively involved with, any Competitive Business, directly or indirectly, as an individual, partner, shareholder, officer, director, principal, agent, trustee or consultant; or 

(D) interfere with, or attempt to interfere with, business relationships (whether formed before, on or after the date of this
Agreement) between the Company or any third parties, including employees, consultants, customers, clients, vendors, suppliers, drug manufacturers, partners, members or investors of the Company. 

(v) Notwithstanding anything to the contrary herein, Executive may, directly or indirectly own, solely as an investment,
securities of any Person engaged in the business of the Company which are publicly traded on a national or regional stock exchange or on the over-the-counter market if
Executive (i) is not a controlling person of, or a member of a group which controls, such Person and (ii) does not, directly or indirectly, own 5% or more of any class of securities of such Person. 

(b) Tolling. Executive understands that if he/she violates the terms of Sections 5.1(a)(i), (ii), (iii) or
(iv) above by engaging in one or more of the prohibited activities during the applicable restrictive period, then the running of the restrictive period will stop, or be “tolled,” during the time of such violation and will begin
running again only when the violation(s) have ceased by voluntary action of Executive or following legal action by the Company to enforce the Agreement. 

5.2 Confidentiality. 

(a) Executive acknowledges that the identity of the clients and customers of the Company, the prices, terms and conditions at,
or upon which, the Company sells its products or provides its services and other non-public, proprietary or confidential information relating to the business, financial and other affairs of the Company
(including, without limitation, any idea, product, trade secret, know-how, research and development, software, databases, inventions, processes, formulae, technology, designs and other intellectual property;
creative or conceptual business or marketing plan, strategy or other material developed for the Company by Executive; or information concerning finances, investments, profits, pricing, costs, products, services, vendors, customers, clients,
partners, investors, personnel, compensation, recruiting, training, advertising, sales, marketing, promotions, government and regulatory activities and approvals – concerning the past, current or future business, activities and operations of
the Company and/or any third party that has disclosed or provided any of same to the Company on a confidential basis) (hereinafter collectively referred to as “Confidential Information”) are valuable, special unique assets of the Company
and that such Confidential Information, if disclosed to others, may result in loss of business or other irreparable and consequential damage to the Company. 

(b) Subject to Section 5.4 below, Executive shall hold in fiduciary capacity, for the benefit of the Company, all
Confidential Information and shall not, at any time during the Employment Period or thereafter (i) retain or use for the benefit, purposes or account of Executive of any other Person, or (ii) disclose, divulge, reveal, communicate, share,
transfer or provide access to any Person outside the Company (other than its professional advisers who are bound by confidentiality obligations), any Confidential Information, without the prior written authorization of the Company. 

 (c) Notwithstanding the foregoing, the term Confidential Information shall not
include information (i) generally known to the public or the trade other than as a result of Executive’s breach of this covenant or any breach of other confidentiality obligations by third parties, (ii) made legitimately available to
Executive by a third party without breach of any confidentiality obligation, (iii) the release of which is deemed by the Board to be in the best interest of the Company, or (iv) the disclosure of which is required by applicable law;
provided, that and subject to Section 5.4 below Executive shall give prompt written notice to the Company of such legal requirement, disclose no more information than is so required, and cooperate with any attempts by the Company to
obtain a protective order or similar treatment. 
 (d) Upon termination of Executive’s employment with the Company for
any reason, Executive shall (i) cease and not thereafter commence use of any Confidential Information or intellectual property (including without limitation, any patent, invention, copyright, trade secret, trademark, trade name, logo, domain
name or other source indicator) owned or used by the Company, (ii) immediately destroy, delete, or return to the Company, at the Company’s option, all originals and copies in any form or medium (including memoranda, books, papers, plans,
computer files, letters and other data) in Executive’s possession or control (including any of the foregoing stored or located in Executive’s office, home, laptop or other computer, whether or not Company property) that contain
Confidential Information or otherwise relate to the business of the Company, except that Executive may retain only those portions of any personal notes, notebooks and diaries that do not contain any Confidential Information, and (iii) notify
and fully cooperate with the Company regarding the delivery or destruction of any other Confidential Information of which Executive is or becomes aware. In addition, on Executive’s last day of employment with the Company, or earlier upon the
request of the Company, Executive shall return to the Company all equipment, data, material, manuals, offering documents, contracts, closing binders, books, records, documents (whether stored electronically or on computer hard drives, disks, thumb
drives, or other storage devices), computer disks, credit cards, keys, I.D. cards, and other Company property, including, without limitation, stand-alone computers or tablets, fax machines, printers, telephones, and other Company electronic devices
in Executive’s possession, custody, or control. 
 5.3 Non-Disparagement. Subject to
Section 5.4 below, Executive agrees that Executive will not disparage the Company or its or their current or former officers, directors, and employees in any way; further, Executive will not make or solicit any comments, statements, or the like
to the media or to others that would be considered derogatory or detrimental to the good name or business reputation of any of the aforementioned entities or individuals; provided, that this Section does not prohibit statements which
Executive is required to make under oath or which are otherwise required by law, provided, that such statements are truthful and made in a professional manner; further provided, that this Section does not prohibit Executive from
making statements which would otherwise be in violation of this Section, provided such statements are made by Executive in response to public statements made by the Company, or its authorized representatives, which are derogatory or detrimental to
the good name or business reputation of Executive. 
 5.4 Permitted Disclosures. Pursuant to 18 U.S.C. § 1833(b), Executive will
not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret of the Company that (a) is made (i) in confidence to a Federal, State, or local government official, either directly
or indirectly, or to Executive’s attorney and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (b) is made in a complaint or other document that is filed under seal in a lawsuit or other
proceeding. If Executive files a lawsuit for retaliation by the Company for reporting a suspected violation of law, Executive may disclose the trade secret to Executive’s attorney and use the trade secret information in the court proceeding, if
Executive (I) files any document containing the trade secret under seal, and (II) does not disclose the trade secret, except pursuant to court order. Nothing in this Agreement is intended to conflict with 18 U.S.C. § 1833(b) or create
liability for disclosures of trade secrets that are expressly allowed by such section. Furthermore, nothing in this Agreement prohibits or restricts Executive from voluntarily reporting possible violations of federal law or regulation to any
governmental agency or entity, including but not limited to the Department of Justice, the Securities and Exchange Commission, the Congress, and any agency Inspector General, or making other disclosures that are protected under the whistleblower
provisions of federal law or regulation. Executive does not need the prior authorization of the Company to make any such reports or disclosures and Executive is not required to notify the Company that he or she has made such reports or disclosures.

 5.5 Acknowledgment of Reasonable Covenants. It is expressly understood and agreed that
Executive and the Company consider the restrictions and covenants contained herein to be reasonable and enforceable, because, among other things, (a) Executive will be receiving compensation under this Agreement or otherwise, (b) there are
many other areas in which, and companies for which, Executive could work in view of Executive’s background, (c) the restrictions and covenants set forth herein do not impose any undue hardship on Executive, (d) the Company would not
have entered into this Agreement but for the restrictions and covenants of Executive contained herein, (e) the restrictions and covenants contained herein have been made in order to induce the Company to enter into this Agreement and
(f) the restrictions and covenants contained herein are for the protection of the Company’s confidential or trade secrets business information and customer or supplier relationships, goodwill and loyalty. 

5.6 Subsequent Employment. Executive agrees to disclose the existence of this Agreement and the restrictions in this Article V (but
nothing further) to any person, firm, corporation or other entity before accepting employment with, engagement by or otherwise working for such person or entity during Executive’s employment with the Company and during the two (2) year
period following termination of Executive’s employment for any reason. Executive further agrees that upon request Executive will disclose to one of the Company’s Vice President(s) of Human Resources the identity of any new employment,
business relationship, or consulting arrangement that Executive is engaged in while Executive is employed and during the two (2) year period after termination of employment for any reason. Notwithstanding the foregoing, this paragraph shall not
prohibit Executive from disclosing historical compensation information (e.g., salary, bonus or long term incentive compensation) to prospective future employers. 

5.7 Modification of the Restrictive Covenants. If, at the time of enforcement of the restrictive covenants set forth herein, a final
judicial determination is made by a court or arbiter of competent jurisdiction that the time or territory or any other restriction contained in this Agreement is an unenforceable restriction against Executive, the provisions of this Agreement shall
not be rendered void but shall be deemed amended to apply as to such maximum time and territory and to such maximum extent as such court may judicially determine or indicate to be enforceable. Alternatively, if any court of competent jurisdiction
finds that any restriction contained in this Agreement is unenforceable, and such restriction cannot be amended so as to make it enforceable, such finding shall not affect the enforceability of any of the other restrictions contained herein. 

ARTICLE VI 
 EMPLOYEE INVENTIONS

 6.1 Ownership of Work Product. Executive acknowledges and agrees that the Company shall solely own, without restrictions or
liability of any kind, all right, title, and interest in and to any and all intellectual property and tangible embodiments thereof, including, but not limited to, all documents, reports, memoranda, drawings, specifications, computer programs, works
of authorship, and other tangible or intangible property and any and all plans, discoveries, creations, compositions, inventions, innovations, processes, technical data, patents and patent applications,
know-how, trade secrets, customer lists, business plans, marketing plans and other competitive data and information, trademarks, service marks, trade names, copyrights and copyright registration applications,
and other materials and designs (whether tangible or intangible) developed or conceived by Executive or provided by the Company or business units to Executive during the course of Executive’s performance of services pursuant to this Agreement
(individually or collectively “Work Product”). 
 6.2 Return of Materials. Executive acknowledges and agrees that Executive
shall not acquire any rights whatsoever in any Work Product and that any and all Work Product, and any other property of Company shall be returned or provided to the Company at any time upon the Company’s demand, and, at the latest, upon
Executive’s separation from Company for any reason. 
 6.3 Title. Executive acknowledges and confirms that it is
Executive’s intention that any and all rights, including any copyright or other intellectual property rights, in any Work Product created by Executive for the Company shall solely and exclusively vest in the Company, and that any such Work
Product shall be considered within the scope of Executive’s employment. The parties agree that the Company is entitled, as author, to the copyright in any copyrightable Work Product and any other rights therein including the right to seek or
not seek statutory registration of any copyright and the right to make such changes therein and uses thereof as the Company in its sole discretion determines. If, for any reason, any Work Product is not considered a work made for hire under the U.S.
Copyright Act, then Executive hereby grants and assigns to the Company, without any requirement of further consideration, all of Executive’s right, title, and interest in and to such Work Product. 

 6.4 Assignment of Rights. Executive agrees to execute such assignments, releases, transfer
documents, and other instruments as the Company may reasonably require in order to vest in the Company complete and absolute title to the Work Product, including all intellectual property rights therein and thereto. For this limited purpose,
Executive hereby appoints the Company as its attorney in fact to execute and deliver to the Company, on behalf of Executive, any and all such documents or instruments. This appointment shall be deemed to be a power coupled with an interest and shall
be irrevocable. Executive agrees to cooperate fully with the Company in any and all acts or actions deemed appropriate by the Company in order to perfect, retain, enforce, and maintain sole and exclusive title in and to the Work Product and all
intellectual property rights therein and thereto. 
 ARTICLE VII 

MISCELLANEOUS 
 7.1
Survival. Sections 4.1 through 4.6 inclusive (as applicable to the relevant circumstance of termination only), Articles V, VI and VII shall survive and continue in full force in accordance with their terms notwithstanding any termination of
Executive’s employment hereunder or termination of the Employment Period. 
 7.2 Notices. All notices, demands or other
communications to be given or delivered under or by reason of the provisions of this Agreement shall be in writing and shall be deemed to have been given when delivered personally, mailed by certified or registered mail, return receipt requested and
postage prepaid, or sent via a nationally recognized overnight courier, or sent via e-mail to the recipient. Such notices, demands and other communications shall be sent to the address indicated below: 

To the Company: 
 Express
Scripts Holding Company 
 One Express Way 

Saint Louis, MO 63121 

Attention: Chief Legal Officer 

To Executive: 
 At the address
in the Company records 
 or such other address or to the attention of such other person as the recipient party shall have specified by prior written notice
to the sending party. 
 7.3 Severability. Whenever possible, each provision of this Agreement shall be interpreted in such manner as
to be effective and valid under applicable law, but if any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or
unenforceability shall not affect any other provision or any other jurisdiction, but this Agreement shall be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision had never been contained
herein. 
 7.4 Complete Agreement. Except to the extent specifically set forth herein, this Agreement constitutes the complete
agreement and understanding between the parties regarding the subject matter hereof and supersedes and preempts any prior understandings, agreements or representations by and between the parties, written or oral which shall automatically terminate
upon the effectiveness of this Agreement; provided, however, that this Agreement shall not supersede or modify the terms of the Nondisclosure and Noncompetition Agreement or any other nondisclosure or noncompetition agreement between
Executive and the Company, and any restricted stock, stock options, performance shares, restricted stock units or other equity awards, deferred compensation and sign on incentives, whether in cash or otherwise, shall be subject to the terms of the
applicable awards, notices or agreements. The applicable provisions of this Agreement amend the terms and provisions of the Incentive Plan to the extent addressed by this Agreement. With respect to all equity grants held by Executive which are not
Covered Equity Awards, such grants shall be treated in accordance with the terms of the Incentive Plan, any award agreement, or any other prior employment agreement with the Company, as applicable. 

 7.5 Counterparts. This Agreement may be executed in separate counterparts, each of which
is deemed to be an original and all of which taken together constitute one and the same agreement. 
 7.6 Successors and Assigns.
Except as otherwise provided herein, all covenants and agreements contained in this Agreement shall bind and inure to the benefit of and be enforceable by the parties to this Agreement and their respective heirs, executors, administrators,
successors and assigns. Except as otherwise specifically provided herein, this Agreement, including the obligations and benefits hereunder, may not be assigned to any party by Executive. In addition to any obligations imposed by law upon any
successor to the Company, the Company will require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and/or assets of the Company to expressly assume and agree to
perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place. Failure of the Company to obtain such assumption and agreement within 30 days after a written
demand therefor is delivered to the Board by Executive shall be a breach of this Agreement and shall entitle Executive to claim Good Reason pursuant to Section 1.20(a) of this Agreement. 

7.7 No Strict Construction. The language used in this Agreement shall be deemed to be the language chosen by the parties hereto to
express their mutual intent, and no rule of strict construction shall be applied to this Agreement. 
 7.8 Descriptive Headings. The
descriptive headings of this Agreement are inserted for convenience only and do not constitute a part of this Agreement. 
 7.9 Governing
Law. This Agreement shall be governed by and construed in accordance with the laws of the State of Missouri, without regard to conflicts of laws principles thereof; provided, however, that issues related to the Incentive Plan or
any grants thereunder shall be resolved in accordance with the laws of the State of Delaware. 
 7.10 Specific Performance. The
Company shall be entitled to enforce its rights under this Agreement specifically, to recover damages and costs (including reasonable attorneys’ fees) caused by any breach or threatened breach of any provision of this Agreement and to exercise
all other rights existing in its favor. Executive agrees and acknowledges that money damages are an inadequate remedy for any breach of the provisions of this Agreement, including, without limitation, Sections 5.1 through 5.3 and Section 5.7,
and that the Company shall be entitled to apply to any court of law or equity of competent jurisdiction (without posting any bond or deposit) for specific performance and/or other injunctive relief in order to enforce or prevent any violations of
the provisions of this Agreement. Further, Executive acknowledges that the forfeiture provision set forth in the termination provisions hereof shall not be construed to limit or otherwise affect the Company’s right to seek legal or equitable
remedies it may otherwise have, or the amount of damages for which it may seek recovery, resulting from breach of this Agreement. 
 7.11
Amendment and Waiver. The provisions of this Agreement may be amended and waived only with the prior written consent of the Company and Executive. 

7.12 Tax Matters. 

(a) Notwithstanding anything to the contrary herein (or any other agreement entered into by and between Executive and the
Company or any incentive arrangement or plan offered by the Company), in the event that any amount or benefit paid or distributed to Executive pursuant to this Agreement, taken together with any amounts or benefits otherwise paid or distributed to
Executive by the Company or any of its subsidiaries (collectively, the “Covered Payments”), would exceed the amount which can be paid to Executive without Executive incurring an Excise Tax, then the amounts payable to Executive under this
Agreement (or any other agreement by and between Executive and the Company or pursuant to any incentive arrangement or plan offered by the Company) may, in the discretion of the Company, be reduced (but not below zero) to the maximum amount which
may be paid hereunder without Executive becoming subject to the Excise Tax (such reduced payments to be referred to as the “Payment Cap”), but only if and 

 
to the extent such reduced amount would provide a greater benefit to Executive than an unreduced payment that would subject Executive to an Excise Tax. In the event Executive receives reduced
payments and benefits as a result of application of this Section 7.12, Executive shall have the right to designate which of the payments and benefits otherwise set forth herein (or any other agreement between Executive and the Company or any
incentive arrangement or plan offered by the Company) will be received in connection with the application of the Payment Cap, subject to the following sentence. Reduction shall first be made from payments and benefits which are determined not to be
nonqualified deferred compensation for purposes of Section 409A of the Code, and then shall be made (to the extent necessary) out of payments and benefits which are subject to Section 409A of the Code and which are due at the latest future
date. 
 (b) Immediately upon a Change in Control, the Company shall notify Executive of any modification or reduction as a
result of the application of this Section 7.12. In the event Executive and the Company disagree as to the application of this Section 7.12, the Company shall select a law firm or accounting firm from among those regularly consulted (during
the twelve-month period immediately prior to the Change in Control that resulted in the characterization of the Covered Payments as parachute payments) by the Company, and such law firm or accounting firm shall determine, at the Company’s
expense, the amount to which Executive shall be entitled hereunder (and pursuant to any other agreements, incentive arrangements or plans), taking into consideration the application of this Section 7.12, and such determination shall be final
and binding upon Executive and the Company. 
 7.13 Executive Representation. Executive hereby represents and warrants to the Company
that the execution and delivery of this Agreement by Executive and the Company and the performance by Executive of Executive’s duties hereunder shall not constitute a breach of, or otherwise contravene, the terms of any employment agreement or
other agreement or policy to which Executive is a party or otherwise bound. 
 7.14 Executive Acknowledgement. Executive acknowledges
that he or she has read and understands this Agreement, is fully aware of its legal effect, has not acted in reliance upon any representations or promises made by the Company other than those contained in writing herein, and has entered into this
Agreement freely based on Executive’s own judgment. 
 7.15 Cooperation. Each party shall provide reasonable cooperation in
connection with any action or proceeding (or any appeal from any action or proceeding) which relates to events occurring during Executive’s employment hereunder. 

7.16 Clawback Policy. This Agreement shall be subject to the Company’s Clawback and Recoupment Policy, or any successor policy, as
it may be in effect from time to time, including, without limitation, any changes required to comply with the Dodd-Frank Wall Street Reform and Consumer Protection Act (the “Policy”), and Executive specifically acknowledges that such
Policy shall apply to compensation and benefit previously provided and that the Committee shall have discretion regarding application of the Policy to this Agreement. 

7.17 Withholding. The Company shall be entitled to withhold from any amounts payable under this Agreement any federal, state, local or
foreign withholding or other taxes or charges which the Company is required or authorized by law to withhold. The Company shall be entitled to rely on an opinion of counsel if any questions as to the amount or requirement of withholding shall arise.

 7.18 Section 409A of the Code. The intent of the parties is that payments and benefits under this Agreement and any other plans or
arrangements in which Executive participates (together, the “Arrangements”) comply with Section 409A of the Code, to the extent subject thereto, and accordingly, to the maximum extent permitted, the Arrangements shall be interpreted and
administered to be in compliance therewith. Notwithstanding anything contained therein to the contrary, Executive shall not be considered to have terminated employment with the Company for purposes of any payments under the Arrangements which are
subject to Section 409A of the Code until Executive has incurred a “separation from service” from the Company within the meaning of Section 409A of the Code. Each amount to be paid or benefit to be provided under this Agreement shall be
construed as a separate identified payment for purposes of Section 409A of the Code. Without limiting the foregoing under any Arrangements, to the extent required in order to avoid an accelerated or additional tax under Section 409A of the Code,
(a) amounts that would otherwise be payable and benefits that would otherwise be provided pursuant to the 

 
Arrangements during the six-month period immediately following an Executive’s separation from service shall instead be paid on the first business day
after the date that is six months following Executive’s separation from service (or, if earlier, Executive’s date of death); provided, however, amounts with respect to the Severance Benefit, the CIC Severance Benefit or the Welfare Benefit
shall accrue with a reasonable rate of interest, as determined in the Company’s sole discretion, from the Termination Date until the date of payment, (b) no Change in Control shall be deemed to have occurred thereunder unless such Change
in Control constitutes a change in control event for purposes of Section 409A of the Code and (c) references to a termination on account of disability shall be deemed to refer to a “disability” for purposes of Section 409A of the
Code. To the extent required to avoid an accelerated or additional tax under Section 409A of the Code, amounts reimbursable to Executive shall be paid to Executive on or before the last day of the year following the year in which the expense was
incurred and the amount of expenses eligible for reimbursement (and in kind benefits provided to Executive) during one year may not affect amounts reimbursable or provided in any subsequent year. The Company makes no representation that any or all
of the payments described in the Arrangements will be exempt from or comply with Section 409A of the Code and makes no undertaking to preclude Section 409A of the Code from applying to any such payment. 

7.19 Arbitration. Executive and the Company agree that any and all disputes between the parties hereto arising from or relating to this
Agreement, and/or any release executed by Executive pursuant to the terms of this Agreement, other than under Article V (with respect to which either party may seek an injunction in aid of arbitration such as an order seeking specific
performance or injunctive or other equitable relief), shall be submitted and decided by binding confidential arbitration before a single arbitrator in accordance with the Employment Arbitration Rules and Mediation Procedures of the American
Arbitration Association (“AAA”) then in effect, and judgment on the award rendered by the arbitrator may be entered in any court having jurisdiction thereof. Venue for the arbitration shall be in St. Louis County, Missouri and the laws as
set forth in Section 7.9 will apply. Any demand for arbitration shall be made within a reasonable time after the claim, dispute, or other matter in question has arisen, and in no event shall any such demand be made after the date when
institution of legal or equitable proceedings based on such claim, dispute or other matter in question would be barred by the applicable statute of limitations. Under no circumstances will either party be subject to punitive damages. Each party
hereto shall bear its costs of the arbitration proceeding. However, to the extent permitted by applicable laws, the prevailing party in the arbitration, as designated by the arbitrator, shall be entitled to recover its reasonable cost of the
arbitration, including, without limitation, its reasonable attorneys’ fees, from the other party as determined by the arbitrator in or following the decision on the merits. Any disputes about the enforcement of this Section 7.19 shall be
submitted to arbitration, and the arbitrator shall have the authority to sever any provision of this Section 7.19 which would render the provision unenforceable as a matter of then existing law in accordance with Section 7.3. 

* * * * * 

 IN WITNESS WHEREOF, the parties hereto have executed this Executive Employment Agreement as of
the Effective Date first above written. 
 THIS CONTRACT CONTAINS A BINDING ARBITRATION PROVISION WHICH MAY BE ENFORCED BY THE PARTIES. 

 

			
	EXPRESS SCRIPTS HOLDING COMPANY
		
	By:	 	  

	Name:	 	
	Title:	 	
	
	EXECUTIVE:
	
	  

	Name:	 	
		
	Date:Exhibit 10.1

 

Bristol-Myers Squibb

March 2, 2017

Dr. Thomas J. Lynch, Jr.

[Address omitted]

Dear Tom,

On behalf of Dr. Giovanni Caforio, Chief Executive Officer, I am pleased to extend our offer to you to join Bristol-Myers Squibb as an employee. This is an exciting time for our Company. We are a recognized leader in our industry with a clear mission to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We look forward to you joining us and being part of a culture that thrives on the passion and collaboration of diverse, talented and valued colleagues across the globe.

Position and Location: Your position will be Executive Vice President and Chief Scientific Officer. I trust that in your conversations with us you have developed a good understanding of the responsibilities and obligations of the role. The position will be located in our New York Office.

Grade and Salary: Your salary grade will be level E13. Your base salary will be $1,000,000 per year and will be paid bi-weekly $38,462. The Bristol-Myers Squibb salary program provides for regular salary reviews.

Annual Bonus Plan:  You will also be a participant in the Bristol-Myers Squibb Annual Bonus Plan. Your annual bonus target is 120% of base salary.  During your initial year of employment, your bonus opportunity will be prorated based on your start date.  During the course of our discussions, you were provided with detailed information explaining our annual bonus program.

Long-Term Incentive Program:  You will be eligible to participate in the Company’s Long-Term Incentive Program and receive annual equity grants, of which 60% will be in performance share units and 40% in market share units (restricted stock units that are tied to the performance of the Company’s stock price). Your annual long-term incentive guideline target will be 270% of base salary to which an individual performance factor may be applied each year. Annual long-term incentive guidelines are reviewed periodically and may change at the sole discretion of the Company.  During the course of our discussions, you were provided with detailed information explaining the Long-Term Incentive Program.

Sign-on Bonus:  You will receive a sign-on bonus of $1,400,000 (taxable income): $700,000 is to be paid not later than 30 days from your start date and $700,000 to be paid on December 30, 2017. Each payment is contingent upon your continued employment and satisfactory performance through the payment date. Should you voluntarily leave Bristol-Myers Squibb or are terminated for cause within 12 months of a payment, you will be required to repay that payment to the Company (net after taxes).  With respect to this cash sign-on bonus, if your employment is terminated by BMS without “Cause”, or you voluntarily terminate for “Good Reason”, as each such term is defined in the Change in Control (CIC) Agreement, annexed hereto,  whether or not such termination is associated with a Change In Control and/or qualifies as a “Qualifying Termination” within the meaning of the CIC Agreement, BMS or any successor thereto shall be obligated to pay you the balance of the unpaid portion of such sign-on bonus within 30 days following such termination.

Restricted Stock Units: Upon joining Bristol-Myers Squibb, you will receive restricted stock units (the “RSU Grant”) under the Bristol-Myers Squibb Stock Award and Incentive Plan (“Current Plan”) valued at $1,400,000. The number of restricted stock units you receive will be determined based on the average of the Company’s closing stock price on the Grant Date and the nine consecutive trading days immediately preceding the Grant Date, and will be communicated to you after your start date. The “Grant Date” is defined as the first business day of the month following your start date (or on your start date if it falls on the first business day of the month). Contingent on your continued employment with the Company, these units will vest 25% per year over four years following the Grant Date. The RSU Grant is subject to the terms and conditions of the Current Plan and the restricted stock unit agreement setting forth the RSU Grant.

 

1

Legal Fees:   BMS has agreed to reimburse you up to a maximum of $25,000 for legal fees associated with the negotiations of the terms and conditions of this offer of employment.

Other:  With respect to indemnification, directors and officers insurance, expense reimbursement/executive travel, you shall be subject to the same policies and programs as are generally applicable to our other Named Executive Officers.

Relocation Policy:  You will be eligible for relocation benefits in accordance with the applicable BMS Relocation Policy previously shared with you.

Vacation: You are eligible for up to 4 weeks of vacation per calendar year, with the opportunity to earn additional weeks of vacation based on years of service. Vacation time is earned at a rate of 10% of the annual allotment for each full calendar month worked. An employee will be considered to have worked a full calendar month if s/he works at least 50% of his/her regular work schedule during that calendar month. Each year Bristol-Myers Squibb celebrates approximately 13 paid holidays. Of these, nine are usually fixed holidays, representing important days of national significance, such as New Year’s Day, President’s Day, and Thanksgiving Day. Each year, Bristol-Myers Squibb will issue its holiday schedule for the following calendar year. The remaining four days are optional holidays.  As a new hire, your optional holidays will be pro-rated based on your start date.

Change in Control / Severance: You will be eligible to participate in the Bristol-Myers Squibb Senior Executive Severance Plan.  You are also a party to the Change-In-Control Agreement attached hereto.

Employee Benefits Program:  We are a Company focused on engaging, empowering and enriching our people. Upon joining Bristol-Myers Squibb you will be eligible for a wide range of compelling and competitive employee benefits that offer choice, flexibility and opportunities to save for the future. Shortly, under separate cover, you will be provided with information about the health, life insurance, and retirement savings benefits available through Bristol-Myers Squibb and the resources that will enable you to begin making your benefit choices. If you receive this information prior to joining the Company, you may make your health and insurance benefits selections before your employment begins, however, your elections will be pending until your actual start date. Otherwise, you will have 31 days from your start date or date you receive your benefit materials in which to enroll in your health and life insurance benefits (see next page). Additionally, under separate cover, you will be provided with information regarding the Bristol-Myers Squibb Company Savings and Investment Program (the 401 (k) Savings Plan). Savings Plan enrollment materials will be sent to you from Fidelity as soon as administratively feasible following your employment date and will provide information about the plan and online tools that are available to you.

Be sure to carefully review the plan information that describes eligibility requirements for each of the plans and the applicable enrollment timeframes. The following chart provides an overview of the types of benefit plans offered provided you meet the eligibility requirements and some general information about the types of enrollment decisions required*:

	
Employee Benefits

	
Enrollment Details

	
Eligibility

	
·      Medical Plans**

·      Dental Plans**

·      Vision Plan**

·      Legal Services Plan **

·      Employee Life Insurance**

·      Dependent Life Insurance

·      Health Care and Dependent Care Flexible Spending Accounts

·      Health Savings Account (available with enrollment in the high deductible Consumer Choice Health Plan option).

	
More information about benefits, enrollment, and how to make your benefit choices through [                     ] will be sent to your home address.

 

For more information about health care benefits, go to:

[                                ]

(no password needed)

 

If you have questions, call Benefits Services at [                ].

	
Employees who are regularly scheduled to work for BMS are eligible to participate.

 

2

	
·     Savings and Investment Program (the 401(k) Savings Plan)

	
Enrollment is available through Fidelity as soon as administratively possible following your first week of employment.

 

To enroll online, go to:

[                          ]

 

To speak with a representative, call the Fidelity Investments Service Center for Bristol-Myers Squibb at [                          ].

	
To be eligible for the Savings Plan you must be scheduled to work at least 1,000 per year.

	
·      Short-Term and Long-Term Disability Plans

·      Business Travel Accident Plan

·      Business Travel Medical Insurance

	
Enrollment is automatic for all eligible employees and is effective as of the first day of active employment.

	
Employees who are regularly scheduled to work for BMS are eligible.

*          The description in the above chart is intended to give you general information regarding the benefits that may be offered. The official plan documents and benefits materials to be distributed regarding each specific plan will control with respect to eligibility to participate in each plan and the time frames required for enrollment. The company reserves the right, in its sole discretion, to amend, modify or eliminate any benefit described herein or otherwise at any time.

**          If you are an eligible employee who does not enroll within 31 days of your start date or receipt of plan materials, whichever is later, you will be provided with default benefit coverage for medical coverage for yourself only, employee life insurance of 1x base pay and no dental, vision or legal services coverage.

Benefits Services is a resource that can address and/or guide you to the answers for certain benefit questions. To reach a Benefits Services representative, call [                 ].

Pre-Placement Requirements: This offer of employment is contingent upon your satisfactory completion of the following:

		•	
A drug screening analysis which must have a negative result. A refusal to submit to a drug screening test will result in the withdrawal of the offer of employment.

Employment At-Will: At all times during your employment with BMS, you will be an employee at-will, you acknowledge and agree that you are employed at-will,  and you and BMS are free to terminate the employment relationship at any time with or without cause and with or without notice.

Employment offer conditioned on acceptance of Agreements:  In exchange for this offer of employment, the benefits outlined in this offer letter, your eligibility to participate in the BMS Annual Bonus Plan (for non- field sales personnel) or incentive compensation plans (for field sales personnel) and as a condition of your employment, you will be required to execute two Agreements, the Employee Confidential Information and Noncompetition Agreement, and Mutual Arbitration Agreement located on the Onboarding Portal. Please review these agreements carefully and sign these documents prior to your first day of work. They must be returned along with your signed offer letter on your first day of employment as instructed below. Although your signature on the Agreements is required, if you begin employment with the Company without signing the Agreements, you will be deemed to have accepted the terms of both Agreements and this offer letter.

BMS Employee Confidential Information and Noncompetition Agreement: The Agreement contains restrictive covenants, including non-compete and non-solicitation provisions, as well as provisions that protect BMS patents, inventions, and confidential information. We also want you to understand that Bristol-Myers Squibb will expect you not to use confidential or proprietary information from present or former employers in your role at Bristol-Myers Squibb Company.

Mutual Arbitration Agreement:   This Agreement requires both BMS and you to agree to bring any employment-related disputes in arbitration rather than in court, and provides that no claims covered by the Agreement may be brought as a class action, collective action, or representative action in court or in arbitration.

 

3

 

As a condition of employment at BMS you will be asked to confirm in writing that you will not disclose to BMS any confidential information in the nature of trade secrets belonging to others. Consistent with this agreement, you are expected to leave behind all of your former employer’s confidential information, including external drives or other storage media (personal or otherwise) and to honor your confidentiality obligations at all times while employed at BMS.

We look forward to you joining Bristol-Myers Squibb and hope you’ll find this offer satisfactory in every respect. Your anticipated start date will be March 16, 2017.   Please bring a signed copy of this offer letter and Employee Confidential Information, Noncompetition Agreement and Mutual Arbitration Agreement on your first day. If you have any questions, please do not hesitate to call me.

Sincerely,

/s/ Ann Powell Judge

Ann Powell Judge

Chief Human Resource Officer

 

I accept this offer with the terms and conditions as outlined in this letter:

	
/s/ Thomas J. Lynch

	 	
3/3/2017

	
Thomas J. Lynch

	 	
Date

4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00268-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00268-of-00352.parquet"}]]